Preliminary study on the efficacy of rituximab in the treatment of idiopathic membranous nephropathy: A single-centre experience
Preliminary study on the efficacy of rituximab in the treatment of idiopathic membranous nephropathy: A single-centre experience is a paper indexed in PICO Portal from OpenAlex.
How many citations does Preliminary study on the efficacy of rituximab in the treatment of idiopathic membranous nephropathy: A single-centre experience have?
Preliminary study on the efficacy of rituximab in the treatment of idiopathic membranous nephropathy: A single-centre experience has 14 citations in the OpenAlex counts PICO Portal stores.
When was Preliminary study on the efficacy of rituximab in the treatment of idiopathic membranous nephropathy: A single-centre experience published?
Preliminary study on the efficacy of rituximab in the treatment of idiopathic membranous nephropathy: A single-centre experience has 2023 year in the PICO Portal index.
What is the open-access status of Preliminary study on the efficacy of rituximab in the treatment of idiopathic membranous nephropathy: A single-centre experience?
Preliminary study on the efficacy of rituximab in the treatment of idiopathic membranous nephropathy: A single-centre experience has gold oa status in the PICO Portal index.
What is the DOI of Preliminary study on the efficacy of rituximab in the treatment of idiopathic membranous nephropathy: A single-centre experience?
The DOI for Preliminary study on the efficacy of rituximab in the treatment of idiopathic membranous nephropathy: A single-centre experience is on the source record.
What is the PMID of Preliminary study on the efficacy of rituximab in the treatment of idiopathic membranous nephropathy: A single-centre experience?
The PMID for Preliminary study on the efficacy of rituximab in the treatment of idiopathic membranous nephropathy: A single-centre experience is on the source record.
What is the OpenAlex record for Preliminary study on the efficacy of rituximab in the treatment of idiopathic membranous nephropathy: A single-centre experience?
The OpenAlex for Preliminary study on the efficacy of rituximab in the treatment of idiopathic membranous nephropathy: A single-centre experience is on the source record.